This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:



Parsing chronological and biological age effects on vaccine responses

old person
Credit: Pixabay/CC0 Public Domain

A new editorial paper was published in Aging, titled, "Parsing chronological and biological age effects on vaccine responses."

Researchers Chris P. Verschoor and George A. Kuchel from Health Sciences North Research Institute in Ontario, Canada, began this by writing that the COVID-19 pandemic illustrated that older age, particularly when accompanied by common chronic illnesses of aging, is arguably the most significant population attributable factor for severe outcomes of acute respiratory infection, including the risk of hospitalization, disability and death.

"In the absence of widely available and highly effective treatments, vaccines remain our most powerful tool to help overcome this through the prevention of primary infection, and far more importantly, by improving clinical outcomes once infection does take place," write the researchers.

In the case of SARS-CoV-2, vaccine effectiveness (VE) against hospitalization was remarkable for dominant strains prior to omicron, whereas for influenza or Streptococcus pneumoniae VE ranges from 80% to <10%, depending on the season and infecting strain/serotype. Nonetheless, for all three pathogens VE decreases with age, which is caused by deficiencies in the capacity of ' immune systems to mount productive and persistent antibody and/or cell-mediated responses to the vaccine. Given that extremely large, costly and typically lengthy clinical trials are often required to estimate VE reliably, the vast majority of human studies assess immune correlates of protection as a proxy to VE. For these studies, antibody related parameters such as neutralization capacity are most commonly employed since they are generally simpler from a technical standpoint and many have been rigorously standardized.

The researchers conclude, "Although informative, cross-sectional studies comparing immune parameters across age groups to understand 'immune aging' risk ignore the degree to which departures from healthy aging might contribute."

More information: Chris P. Verschoor et al, Parsing chronological and biological age effects on vaccine responses, Aging (2023). DOI: 10.18632/aging.204572

Provided by Impact Journals LLC
Citation: Parsing chronological and biological age effects on vaccine responses (2023, March 27) retrieved 23 September 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

COVID-19 vaccine protection lasts at least six months after second dose, finds study


Feedback to editors